Top

Quality of Life Research

Gepubliceerd in:

01-08-2011

Validation of the AQLQ12+ among adolescents and adults with persistent asthma

Auteurs: Kathleen W. Wyrwich, Andrea M. Ireland, Prakash Navaratnam, Hendrik Nolte, Davis F. Gates Jr.

Gepubliceerd in: Quality of Life Research | Uitgave 6/2011

Abstract

Background

To date, there is limited psychometric evidence on the Asthma Quality of Life Questionnaire (AQLQ12 +) among populations that include adolescents and adults.

Objective

To provide evidence of the psychometric properties of the AQLQ12+ as a measure of asthma-specific quality of life (QOL) in patients with persistent asthma treated with a combination of inhaled glucocorticoid and long-acting beta2-agonist, as well as explore the predictors of at least a minimally important AQLQ12+ improvement.

Methods

The psychometric properties of the AQLQ12+ were assessed through post hoc analysis of two large (n = 740 and 778) Phase III, randomized, double-blinded, placebo-controlled efficacy studies of mometasone furoate/formoterol fumarate (MF/F) combination compared with monotherapy in subjects with persistent asthma previously treated with either low-dose or medium-dose inhaled glucocorticoids.

Results

With 15% and 8% participation from 12- to 17-year olds, blinded trial data demonstrated excellent reproducibility (ICC range: 0.76–0.85) and moderate-to-strong construct validity with other measures of asthma health at baseline and over time for the AQLQ12 +. A greater percentage of the MF/F treatment group (44%) achieved an important change at 26 weeks on the AQLQ12+ compared with formoterol fumarate (F, 23%) and placebo (18%) treatment groups in the low-dose study (P < 0.001) and the medium-dose study (50% (MF/F) versus 34% (F) and 23% (placebo); P < 0.001). Pre-randomization nighttime awakenings and rescue medications use were significant predictors of AQLQ12+ improvement.

Conclusions

These findings provide strong support for the measurement properties of the AQLQ12+ among patients with persistent asthma and confidence in the AQLQ12+ improvements demonstrated by the MF/F treatment group.

vorige artikel Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia

volgende artikel PedsQL™ Cognitive Functioning Scale in pediatric liver transplant recipients: feasibility, reliability, and validity

Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention (updated 2008). Available at: http://www.ginasthma.org/Guidelineitem.asp??l1=2&l2=1&intId=60.

Gergen, P. J., Arbes, S. J., Jr., Calatroni, A., Mitchell, H. E., & Zeldin, D. C. (2009). Total IgE levels and asthma prevalence in the US population: Results from the National Health and Nutrition examination survey 2005–2006. The Journal of allergy and clinical immunology, 124(3), 447–453.PubMedCrossRef

Mannino, D. M., Homa, D. M., Akinbami, L. J., Moorman, J. E., Gwynn, C., & Redd, S. C. (2002). Surveillance for asthma–United States, 1980–1999. MMWR Surveill Summ, 51(1), 1–13.

Juniper, E. F., Svensson, K., Mork, A. C., & Stahl, E. (2005). Modification of the asthma quality of life questionnaire (standardised) for patients 12 years and older. Health Qual Life Outcomes, 3, 58.PubMedCrossRef

Juniper, E. F., Buist, A. S., Cox, F. M., Ferrie, P. J., & King, D. R. (1999). Validation of a standardized version of the asthma quality of life questionnaire. Chest, 115(5), 1265–1270.PubMedCrossRef

Mancuso, C. A., Rincon, M., McCulloch, C. E., & Charlson, M. E. (2001). Self-efficacy, depressive symptoms, and patients’ expectations predict outcomes in asthma. Medical Care, 39(12), 1326–1338.PubMedCrossRef

Almada Lobo, F., & Almada-Lobo, B. (2008). Quality of life in asthmatic outpatients. Journal of Asthma, 45(1), 27–32.PubMedCrossRef

Apter, A. J., Reisine, S. T., Affleck, G., Barrows, E., & ZuWallack, R. L. (1999). The influence of demographic and socioeconomic factors on health-related quality of life in asthma. The Journal of allergy and clinical immunology, 103(1 Pt 1), 72–78.

(July 2007). National heart, lung, and blood institute. Expert panel report 3: Guidelines for the diagnosis and management of asthma. Bethesda, MD, National Asthma Education and Prevention Program, National Heart, Lung and Blood Institute, National Institutes of Health.

10.

Crapo, R. O. (1989). Reference values for lung function tests. Respiratory CRE, 34, 626–637.

11.

Polgar, G., & Promadhat, V. (1971). Pulmonary function testing in children: Technique and standards. Philadelphia, PA: W.B. Saunders.

12.

Nathan, R. A., Nolte, H., & Pearlman, D. S. (2010). Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 microg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled corticosteroids. Allergy and Asthma Proceedings, 31(4), 269–279.PubMedCrossRef

13.

Juniper, E. F., O’Byrne, P. M., Guyatt, G. H., Ferrie, P. J., & King, D. R. (1999). Development and validation of a questionnaire to measure asthma control. European Respiratory Journal, 14(4), 902–907.PubMedCrossRef

14.

van den Nieuwenhof, L., Schermer, T., Eysink, P., Halet, E., van Weel, C., Bindels, P., et al. (2006). Can the asthma control questionnaire be used to differentiate between patients with controlled and uncontrolled asthma symptoms? A pilot study. Family Practice, 23(6), 674–681.PubMedCrossRef

15.

van den Nieuwenhof, L., Schermer, T., Heins, M., Grootens, J., Eysink, P., Bottema, B., et al. (2008). Tracing uncontrolled asthma in family practice using a mailed asthma control questionnaire. Annals of Family Medicine, 6(Suppl 1), S16–S22.PubMedCrossRef

16.

Juniper, E. F., Svensson, K., Mork, A. C., & Stahl, E. (2005). Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respiratory Medicine, 99(5), 553–558.PubMedCrossRef

17.

Santanello, N. C., Barber, B. L., Reiss, T. F., Friedman, B. S., Juniper, E. F., & Zhang, J. (1997). Measurement characteristics of two asthma symptom diary scales for use in clinical trials. European Respiratory Journal, 10(3), 646–651.PubMed

18.

Hays, R., & Revicki, D. A. (2005). Reliability and validity (including responsiveness). In P. Fayers & R. Hays (Eds.), Assessing quality of life in clinical trials (pp. 25–39). New York: Oxford University Press.

19.

Streiner, D. L., & Norman, G. R. (2003). Health measurement scales: A practical guide to their development and use. Oxford: Oxford University Press.

20.

Fleiss, J. L. (1981). Statistical methods for rates and proportions. New York: Wiley.

21.

Hinkle, D. E., Jurs, S. G., & Wiersma, W. (1988). Applied statistics for the behavioral sciences. Boston: Houghton Mifflin.

22.

Juniper, E. F., Guyatt, G. H., Willan, A., & Griffith, L. E. (1994). Determining a minimal important change in a disease-specific quality of life questionnaire. Journal of Clinical Epidemiology, 47(1), 81–87.PubMedCrossRef

Titel: Validation of the AQLQ12+ among adolescents and adults with persistent asthma
Auteurs: Kathleen W. Wyrwich
Andrea M. Ireland
Prakash Navaratnam
Hendrik Nolte
Davis F. Gates Jr.
Publicatiedatum: 01-08-2011
Uitgeverij: Springer Netherlands
Gepubliceerd in: Quality of Life Research / Uitgave 6/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-010-9821-3

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Background

Objective

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2011

Weight loss and changes in generic and weight-specific quality of life in obese adolescents

Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States

Cross-cultural adaptation and validation with reliability, validity, and responsiveness of the Italian version of the Oxford Hip Score in patients with hip osteoarthritis

Psychosocial interventions to improve quality of life in prostate cancer survivors and their intimate or family partners

Trait anxiety predicts disease-specific health status in early-stage breast cancer patients

A new test of the construct validity of the CarerQol instrument: measuring the impact of informal care giving